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Abstract
Background To compare the efficacy of the Newcastle infant
dialysis and ultrafiltration system (Nidus) with peritoneal
dialysis (PD) and conventional haemodialysis (HD) in infants
weighing <8 kg.
Methods We compared the urea, creatinine and phosphate
clearances, the ultrafiltration precision, and the safety of the
Nidus machine with PD in 7 piglets weighing 1–8 kg, in a
planned randomised cross-over trial in babies, and in babies
for whom no other therapy existed, some of whom later
graduated to conventional HD.
Results Two babies entered the randomised trial; 1 recovered
rapidly on PD, the other remained on the Nidus as PD failed.
Additionally, 9 babies were treated on the Nidus on humani-
tarian grounds: 3 because of failed PD, and 3 with permanent
kidney failure later converted to conventional HD. We
haemodialysed 10 babies weighing between 1.8 and 5.9 kg
for 2,475 h during 354 Nidus sessions without any clinically
important incidents, and without detectable haemolysis.
Single-lumen vascular access was used with no blood priming
of circuits. The urea, creatinine and phosphate clearances
using the Nidus were around 1.5 to 2.0 ml/min in piglets
and babies, and were consistently higher than PD clearances,
which ranged from about 0.2 to 0.8 ml/min (p≤0.0002 for
each chemical). Ultrafiltration was achieved to microlitre pre-
cision by the Nidus, but varied widely with PD. Fluid removal
using conventional HD was imprecise and resulted in some
hypovolaemic episodes requiring correction.
Conclusion The Nidus can provide HD in the Pediatric
Intensive Care Unit (PICU) and outpatient intermittent HD
without blood priming for babies weighing <8 kg, It generates
higher dialysis clearances than PD, and delivers more precise
ultrafiltration control than either PD or conventional HD.
Keywords Infant .Acute renal failure .Chronic renal failure .
Renal replacement therapy
Introduction
Dialysing small babies is challenging formany reasons. Vascular
access for haemodialysis (HD) modalities is problematic as the
size of the central venous line (CVL) required for adequate blood
flow is disproportionately large for the size of the baby especially
when a double lumen line is needed (Poiseuille’s law: flow is
proportional to the fourth power of the internal radius).
Peritoneal dialysis (PD) is frequently used to support in-
fants after open-heart surgery [1–3], and sometimes to treat
very-low-birthweight babies [4, 5] where conventional HD is
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typically insurmountably challenging [6]. Larger critically ill
infants with multi-organ failure are often treated with a variety
of continuously delivered HD modalities (continuous renal
replacement therapy, CRRT) [7]. Most babies with chronic
renal failure are treated using PD [8, 9], with HD only used for
bridging [10].
Peritoneal dialysis is technically simpler than HD [6, 10,
11]; there is no lower size limit for its use, but complications are
common in the smallest patients [4–6, 11]. Ultrafiltration (UF)
is unpredictable [10], and chemical clearance (including am-
monia) less efficient [7, 12], especially in unstable babies who
develop splanchnic vasoconstriction and who also risk devel-
oping necrotising enterocolitis. This renders PD impossible, as
do abdominal surgery and congenital abdominal wall defects.
Conventional HD and CRRTmachines cannot control fluid
balance better than ±30 ml/h [13], and therefore are not
licensed for babies weighing <8 kg (or approved for use in
children of <20 kg in the USA). The recommended minimum
7-Fr, dual-lumen vascular access lines and continuous 40 ml/
min blood flows [7] are difficult to achieve in the smallest
babies. Their relatively large circuit volume (≥60 ml) pro-
duces sudden dilution of blood on commencing treatment if
primed with crystalloid, and increases the risk of anaemia with
circuit loss. Blood priming risks exposing the baby abruptly to
aberrant chemical and pH changes, which are reduced by pre-
dialysing the circuit [6, 14]. Even in infants, exposure to blood
transfusions may increase the risk of developing tissue-type
sensitisation, which may affect transplant matching later [15].
The CARPEDIEMdevice has only just become available with
a miniaturised conventional circuit (27 ml) for babies as small
as 2.5 kg [16]. Its fluid pump imprecision is ±7.5 %.
In 1995, we therefore designed a novel HD circuit, which
operated by different principles. It was driven by syringes, and
uncoupled the baby’s blood flow capacity from the require-
ments of the dialysis filter [17]. In 2005, we reported the
results of automating this as a miniaturised machine (circuit
volume 13 ml), with which we treated four babies weighing
between 800 g and 3.4 kg, using a single-lumen access line,
and without the need for blood-priming [18]. We have subse-
quently developed this device into the Newcastle infant dial-
ysis and ultrafiltration system (Nidus). Here, we compare the
efficacy of the Nidus with that of PD in piglets and in babies,
and consider its safety and clinical value.
Materials and methods
Subjects
Piglets
We simultaneously measured the chemical clearances and UF
rates produced by PD and the Nidus in anaesthetised piglets
weighing between 1 and 8 kg, in a non-recovery study in
accordance with the Animals (Scientific Procedures) Act,
1986, whilst infusing urea and creatinine to simulate renal
failure. We studied one animal to evaluate unforeseen prob-
lems before repeating it in 6 further piglets to minimise the
numbers of animals used. To test UF control, we used PD
dialysate glucose concentrations of 1.36 to 3.86 %, and set the
Nidus to operate at UF rates between 0 and 40 ml/h. We
measured serial plasma haemoglobin concentrations to detect
haemolysis.
Babies
We measured dialysis clearances up to twice daily in infants
weighing ≤8 kg who were being treated by the Nidus and/or
PD by collecting effluent dialysate fluid when bloods were
being tested for clinical reasons. We measured the plasma
haemoglobin daily for the first two days to detect haemolysis.
We studied two groups of babies. The RCT group were
infants who would normally have received PD, typically after
open-heart surgery, but who instead were to be treated sequen-
tially with both PD and the Nidus on alternate days for 4 days,
in a cross-over controlled trial where the starting modality was
randomised after obtaining informed parental consent. Vascu-
lar access was obtained through the 20-gauge lumen of a
routinely sited 4.5-Fr triple-lumen central line. The study
had National Research Ethics Service (NRES) approval (11/
YH/0449) and was conducted according to the 1964 Declara-
tion of Helsinki. The COMP group consisted of babies who
were treated on compassionate grounds because their clini-
cians judged that their best chance of survival was to be
dialysed on the Nidus. This had approval from our hospital’s
Clinical Governance and Quality Committee, and families
were fully informed about its experimental nature before they
signed consent for its use. Assessments were also carried out
in any of the COMP infants who were subsequently managed
with PD.
Adult volunteer
In order to re-engineer the Nidus for some babies’ require-
ments, such as increasing the sampling speed, we needed to
test it for safety before clinical use. We undertook this on an
adult volunteer using an antecubital vein, with NRES approv-
al and fully informed consent.
Dialysis methods
The Nidus
This syringe-driven machine repeatedly withdraws 5 to 12.5
ml aliquots of blood from a single-lumen central venous line,
passes and returns it across a dialysis filter, and then back to
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the baby. At a blood flow rate of 20 ml/min, this processes
5 ml of blood each minute. The circuit (Fig. 1) has two
operating syringes (1), a high-flux polysulfone 0.045 m2 filter
(2), a heparin syringe (3), pumped dialysate (4), a pressure
transducer (5) and an air-detector (6), and self-primes with
4.3 ml of heparinised saline, giving a minimum operating
volume of 9.3 ml. Ultrafiltration from 0 to 60 ml/h is precisely
controlled in 3.2 μl steps by differential syringe movements.
The circuit may be connected to a heparinised saline “dum-
my” [7], or the infant line [8], and blood may be sampled [9]
for testing. The pressure-control pattern and exact circuit
position are displayed on a touch-screen, which also informs
the operator about warning and stop-alarm states. If the line is
poor, the Nidus instantly slows its rate of blood withdrawal
from the baby and informs the operator. It records its precise
operating status and syringe positions every one-tenth of a
second, and has battery back-up. The circuits have been
designed for up to 24 h of continuous use.
Peritoneal dialysis
We performed manual PD using Tenckhoff catheters and
bicarbonate-based dialysate, typically with 30-min cycles. In
the piglets we used 40-ml/kg fill volumes, but to minimise the
risk of acute hydrothorax in the babies we commenced at
10 ml/kg and aimed to increase to 40 ml/kg over 6 days if
tolerated [19].
Assessments
Chemical clearance measurements
We measured “instantaneous” dialysis clearances of urea,
creatinine and phosphate using both treatment modalities
by assaying their concentrations simultaneously in blood
and in timed and measured effluent dialysate fluid sam-
ples, and using standard clearance formulae. We used
enzymatic creatinine assays to avoid the effect of non-
creatinine chromogens, such as glucose [20].
Ultrafiltration measurements—direct
For the Nidus, we determined the UF precision in vitro
and in piglets by weighing the fluid removed to the nearest
0.1 g during isolated UF, and during dialysis and ultrafil-
tration by monitoring the combined weight of the fresh
and waste dialysate bags. For PD, we measured the UF
volume after every PD cycle. In both cases, we assessed
UF adequacy by comparing the volumes of fluid removed
during treatment with the prospectively agreed clinical
targets.
Ultrafiltration measurements—indirect
In two clinically stable babies who underwent regular outpa-
tient dialysis sessions of approximately 4-h on the Nidus, and
subsequently on a conventional paediatric HD machine
(Gambro AK200), we repeatedly estimated their fluid balance
bymeasuring the weight changes to within 10 g at the start and
finish of each session.
Statistical analysis
We expressed clearances as absolute values (ml/min), and
per 1.73 m2 of body surface area, estimated from weight
alone using Boyd’s self-adjusting power equation [21]
(although this is likely to be an overestimate in piglets).
We used paired t tests (P-t) to compare clearances within
the same piglets, and independent t tests (I-t) between
different babies or piglets. We compared UF values within
the same piglets using the Wilcoxon matched pairs sign
rank test (WMT), because their values were non-normal,
and linear regression to compare the relation between
clearance values and body weight. All tests were two-
sided with probability (p) values expressed to one
significant figure.
Fig. 1 The Newcastle infant dialysis and ultrafiltration system (Nidus
machine) in use. The numbered parts are described in the text. The parents
gave their informed consent to use the photograph
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Results
Subjects studied
Piglets
Seven piglets (1.1 to 7.2 kg) were “treated” with both the
Nidus and PD. Five were studied for 6 h each, and 2 were
dialysed for 24 h.
Babies
Eleven babies were dialysed (6 boys; Table 1) at a median
weight of 3.5 kg, and range 1.8 to 7.0 kg. An RCT was
attempted, but only 2 babies were enrolled through this
route, in part because of the lack of equipoise in this
clinical setting. Of these 2 infants, 1 (case 10) only
required PD for <24 h, and 1 (case 3) was only treated
with PD for 10 h as it was not tolerated clinically. Nine
infants were treated by the Nidus on compassionate
grounds, 3 of whom also had periods of PD. Thus, 1 baby
had PD alone, 6 had Nidus treatment alone, and 4 had
both modalities, over a total of 192 h of PD, and 2,475 h
of HD during 354 treatments.
Chemical clearances
Piglets
The absolute clearances of urea, creatinine and phosphate
delivered by the Nidus were similar in all the animals
regardless of size (linear regressions vs weight, p=0.3 to
0.9), and were considerably higher than the clearances
delivered by PD (Fig. 2a; p≤0.0002 for each, P-t). The
absolute PD clearances for each chemical increased with
body weight (p≤0.04 for each, I-t), as would be expected
when dialysis cycle volumes are prescribed per kilogram.
The Nidus urea clearances (2.14 ml/min) were higher than
for creatinine or phosphate (1.54 and 1.56 ml/min,
p<0.001 for each, P-t), consistent with polysulfone, hav-
ing a small molecule sieving coefficient of 1, and urea also
being distributed inside the blood cells. For PD, the clear-
ance of urea was also higher than that of creatinine for the
same reason (0.86 vs 0.40 ml/min, p=0.005, P-t), but that
of phosphate was lower (0.29 ml/min, p=0.001, P-t),
consistent with its slow movement across the peritoneum
in older children [22]. The PD clearances per 1.73 m2
in the smaller animals (Fig. 2b). The absolute clearances
of each chemical using the Nidus and PD are compared in
Fig. 3b, and clearance differences for each animal are
shown as open circles in Fig. 4.
Babies
The infants were dialysed for different periods of time accord-
ing to their clinical needs, ranging from just one treatment
session to many over periods of months (see Table 1 and
Fig. 5, which displays all of our clearance measurements).
To make comparisons with the piglet data, we only analysed
the first measurements made for each baby. For clinical rea-
sons, the PD cycle volumes and frequencies varied for these
infants, which influenced chemical clearances, and the hourly
per-kg throughput of dialysate are shown in Table 1.
Figure 3 shows that the Nidus delivered higher chemical
clearances than PD (p≤0.0001, I-t). The gains for each of the
three chemical clearances from using HD rather than PD were
also similar for the 4 infants who experienced both treatments,
and close to the mean gains seen in the piglets (Fig. 4, p values
0.8 to 1.0, I-t).
Ultrafiltration
Nidus
The UF was precise when measured directly by weighing the
fluid removed with a detection limit of 0.25 %. Our repeated
indirect UF assessments in 2 babies weighing about 6 kg
showed good precision; the difference between their predicted
and actual weights at the end of treatment had a standard
deviation (SD) of ±17 g, and range of −33 to +25 g (Fig. 6).
Using a Gambro AK200 paediatric HDmachine, the variation
was much greater, with an SD of ±96 ml (p=0.003 for each
child), and a range of −465 to +215 ml; saline boluses were
required on several of these occasions for hypovolaemic
symptoms.
Peritoneal dialysis
The piglets absorbed 0.4 to 14.5 ml/kg/h of water when
dialysed with 1.36 % glucose dialysate, but 6 of the 7 lost
from 3.0 to 11.4 ml/kg/h with 3.86 % glucose bags
(Fig. 7). One animal absorbed very large fluid volumes
with any strength bag. Failure to produce an adequate UF
volume was a clinical problem in 4 of the 6 babies we
treated with PD. When baby 1 had PD introduced (after
closure of his colostomy), he continued to need the Nidus
for fluid removal. Baby 2 lost UF control on PD after
developing fungal peritonitis. Baby 11 was on long-term
PD, but transiently lost his UF capacity when he devel-
oped large hydrocoeles, and he required Nidus treatment
to prepare him for his herniotomy procedures. Baby 3 did
not produce any ultrafiltrate or adequate dialysis during
his 10 h on PD, during which time his peripheral perfusion
and oxygen saturation fell and he became more unstable
and difficult to ventilate. For this reason, the clinician
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were the same for all sized piglets (linear regressions,
p=0.08 to 0.6), whereas the Nidus clearances were higher
ceased using PD. He improved after being restarted on
treatment with the Nidus.
Access, anticoagulation, haemolysis and air detection using
the Nidus
Most babies treated acutely had 20-gauge, 10-cm ve-
nous cannulas that typically allowed blood withdrawal
at 20 ml/min, although sometimes the Nidus needed to
slow automatically with these lines. We used 6.5-Fr
venous lines of 1.6 mm in internal diameter and with
multiple side holes (Tessio) for children on long-term
renal replacement. The performance of the circuits and
dialysis filters remained unchanged during 36 h of con-
tinuous use.
We were able to successfully anticoagulate the circuit
with heparin to an ACT to 120–160 s, whereas the ACT
range typically used during HD is 180–220 s. There
was no excessive bleeding. Early in the study, some
circuits clotted if inappropriately high UF rates were
set for the baby’s physiological state; see the section
Nidus development below.
The plasma haemoglobin concentrations remained normal
in all the piglets and babies, excluding significant haemolysis.
Table 1 Clinical details of the 11 infants treated with dialysis
Case Sex Age
(days)
Weight
(kg)
Cause of renal failure Prior
ECMO
Reason for using haemodialysis
and/ or PD
Haemodialysis PD hourly dialysate
flow
Sessions Hours (ml/kg)
1 Male 3 1.8 ESRF, solitary MCD Had colostomy for anal atresia 163 847 21
2 Female 58 3.3 ESRF, bilateral MCD Fungal peritonitis with initial PD 11 66 28
3 Male 6 3.5 Post-cardiac surgery RCT, but could not tolerate PD 5 75 20
4 Female 37 4.0 SVT causing ESRF + Had colostomy for NEC 158 1,236
5 Female 6 4.1 Meconium aspiration,
PPHN
+ Had NEC with abdominal
distension
5 85
6 Female 20 2.6 TBM and post-cardiac
surgery
+ Open chest and high IPPV
pressures
5 110
7 Female 6 2.4 Methyl-malonic
acidaemia
PD inefficient for ammonia
removal
4 12
8 Male 349 7.0 Post-cardiac surgery + Gut perforation with previous PD 1 24
9 Male 5 3.1 Complex heart disease Gut resection for NEC 1 12
10 Male 27 4.0 Post-cardiac surgery + Started on PD and recovered
promptly
0 0 20
11 Male 228 5.2 ESRF, renal dysplasia Temporary PD failure 1 8 41
Totals 354 2,475
ECMO extra-corporeal membrane oxygenation, PD peritoneal dialysis, ESRF end-stage (permanent) kidney failure,MCDmulticystic dysplastic kidney,
RCT randomised controlled dialysis trial, SVT supra-ventricular tachycardia, PPHN persistent pulmonary hypertension, NEC necrotising enterocolitis,
TBM tracheo-broncho-malacia requiring stenting, IPPV intermittent positive pressure ventilation
Fig. 2 Chemical clearances in 7
piglets treated using the
Newcastle infant dialysis and
ultrafiltration system (Nidus,
solid symbols and lines) and by
peritoneal dialysis (PD, open
symbols and broken lines),
expressed a as absolute values,
ml/min/piglet, and b relative to
body surface area, ml/min/
1.73 m2. In this case, the
ultrafiltration was set at 40 ml/h
for Nidus, and 3.86 % glucose
dialysate was used for PD.
Squares urea, triangles creatinine,
circles phosphate
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There were two reported clinical incidents in baby 4 involving
small air leaks into the circuit, both of which stopped the
machine virtually instantaneously, isolating the baby’s blood
line from risk, and triggered appropriate visual and audible
alarms.
Feedback and usability
The nursing and medical staff found the Nidus easy to
operate and most preferred it to PD because of im-
proved UF control and because it did not destabilise
babies on commencement of therapy. Some parents
commented on the machine’s simplicity and found that
the onscreen display helped their understanding of the
procedure, which they found reassuring. We downloaded
the complete Nidus activity record after each patient’s
treatment for teaching, machine development, and for
clinical review by the medical, nursing and engineering
teams.
Nidus development
Before 2010, the early pilot machines had only been used by a
small specialist medical and nursing team for babies under
4.5 kg, for continuous therapy on compassionate grounds
when there was no alternative. We made new developments
during this study in response to challenges that arose because
the Nidus was also used on larger babies, sometimes for
intermittent outpatient HD, and because of feedback we ob-
tained when it was operated by a wider range of paediatric
staff.
Early in the study, some filters clotted when attempts were
made to remove fluid from oedematous babies who in retro-
spect were recognised to have had intravascular hypovolaemia.
Initially, the device reported the rising filter operating pressure,
which could be serially overridden, without directing the nurse
to recognise its cause, or to reduce the UF rate setting. We
solved this problem by introducing a software algorithm to
automatically regulate the UF delivery rate according to chang-
es in the dialyser’s operating pressure, and to indicate to the
operator when this was happening.
In response to the clearance needs of babies up to 8 kg on
intermittent dialysis, and to increase the efficiency of ammo-
nia removal from babies with metabolic diseases, we re-
engineered the Nidus during the latter part of the study so that
it could bemade to run both at its standard blood sampling rate
Fig. 3 Absolute clearances of
urea, creatinine and phosphate a
in infants, and b in piglets,
comparing those generated by the
Nidus machine (dark grey
columns) and by Peritoneal
dialysis (light grey). For the
babies, the values were the first
ones measured in that child. The
number of cases is shown on each
column.*Comparing babies with
unpaired t tests; ϕcomparing each
piglet using paired t tests
Fig. 4 Differences between the absolute clearances of urea, creatinine
and phosphate delivered by the Nidus machine and Peritoneal dialysis,
ml/min, for the 4 babies (solid symbols) and 7 piglets (open symbols) that
received both treatments.Means and individual values are shown.p values
are for independent t tests comparing the baby and piglet clearances
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of 20 ml/min, and at 45 ml/min. This corresponds
approximately to the blood flow that can be obtained
through a 6.5-Fr Tessio line, or a standard 16-gauge
intravenous cannula (length 45 mm) at −300 mm Hg.
This increased the chemical clearances proportionately
(nearly 2½-fold) in an adult volunteer and in baby 4, in
whom it was used for several dialysis sessions. We have
subsequently increased the higher rate to 50 ml/min,
and are currently modifying the filter geometry to opti-
mise the operating pressures at this speed.
Patient outcomes
Acute renal failure
Four of the 6 babies treated for acute renal failure with
the Nidus recovered normal kidney function. Two had
treatment withdrawn, one because she had evidence of
brain damage owing to her pre-dialysis ammonia levels
caused by methyl-malonic acidaemia, and one because
he had an inoperable cardiac abnormality.
Urea
Phosphate
Creatinine
Fig. 5 All of the absolute urea, creatinine and phosphate clearances
measured in the babies, identified by their case number in Table 1.
Treatments with the Nidus machine are shown with solid symbols, and
Peritoneal dialysis treatments with open symbols. The same logarithmic
time scale was used for all to improve the visual separation of individual
babies’ values
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Chronic renal failure
One baby on chronic PD developed large hydrocoeles and
failure of ultrafiltration. He was treated with the Nidus peri-
operatively and then resumed PD successfully. Three other
babies with permanent renal failure were transferred success-
fully to conventional HD on Gambro AK200 machines as they
grew. In each case, growth faltering occurred as they reached
about 5 kg. In the last of these (case 4) we responded to the
stalled weight gain by increasing the dialysis prescription, both
by increasing her treatment time, and by re-engineering the
Nidus to operate at 45 ml/min. Her weight gain then accelerat-
ed, which allowed us to transfer her onto a conventional HD
machine at 5.9 kg, and thus for her to be managed by her local
paediatric dialysis centre. Case 1 developed liver cancer 2 years
later and died. Case 2 has had a successful live donor transplant,
and case 4 remains well on HD.
Discussion
At the time of the study there were no machines licensed to
deliver renal replacement for babies weighing between 800 g and
8 kg because of the imprecisions and circuit volume limitations
that are inherent in conventional system designs. We have de-
veloped a unique device, the Nidus, which can provide
haemodialysis and precise ultrafiltration across this weight range.
The single-lumen access it requires is easier to achieve, it auto-
matically slows its sampling rate from the baby if the access line
is narrow and the blood flow rate of the baby’s line is uncoupled
from the flow rate that the dialysis filter requires. Furthermore, it
requires less anticoagulation than other extracorporeal circuits in
clinical use. Because the circuit volume is less than 10ml, it does
not require blood priming, even for babies of 800 g, and its
ultrafiltration control is delivered to microlitre precision.
Because the principles of delivering PD are technically
simple [6, 10, 11], and it is relatively cheap to provide, it will
continue to play a role in treating some acutely ill babies.
However, the unpredictability of its fluid control, lower chem-
ical clearances, and access complications maymake the Nidus
a better choice in some cases. Also, the Nidus can provide
treatment for babies with necrotising enterocolitis, abdominal
wall defects, or after abdominal surgery, when there are few
other options. PD is likely to remain the treatment of choice
for managing infants with chronic renal failure [8, 9], but
when this is contraindicated or fails, the Nidus could provide
a short- or long-term treatment bridge.
Commercially available HD and continuous veno-venous
haemofiltration (CVVH) devices require dual-line or double-
lumen access with relatively large central venous lines, and
they demand a minimal supply of blood from the baby to
prevent the filter from clotting. They also require relatively
large extracorporeal circuits to incorporate pump inserts and a
compliance chamber with a blood–air interface, which neces-
sitates either blood priming for small babies, or priming with
saline, which will induce a sudden haemodilution at connec-
tion, often followed by a blood transfusion to correct the
Fig. 6 The estimated fluid balance errors in 2 babies who weighed about
6 kg, during routine outpatient dialysis and ultrafiltration sessions of 3 to
5 h, using the Nidus machine first, and then after changing them to a
conventional paediatric haemodialysis machine (Gambro AK200). Fluid
overload appears above the 0-line, dehydration below. The grey line
indicates the expected error range of ±20 g from weighing the babies
twice to the nearest 10 g
Fig. 7 The ultrafiltration rates achieved in 7 piglets on peritoneal dialy-
sis, using solutions with glucose concentrations of 1.36, 2.27 and 3.86%.
Positive values indicate fluid removal; negative ones indicate fluid gain
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induced anaemia. For the Gambro Prismaflex, a circuit vol-
ume of 60ml [13] makes it desirable to blood prime the device
for babies of <5 kg. The proposed USAminiaturised prototype
will have a circuit volume of 43ml,[23] and the CARPEDIEM
circuit at 27 ml does not need blood priming for babies of
>2.5 kg [16], but this machine has only just become available.
Ultrafiltration rates in conventional HD and CVVH systems
are regulated by making adjustments to the pressure gradients
operating across the dialysis membranes according to the fluid
shifts that the machine assesses by continuously weighing the
fresh and waste dialysate bags. The imprecision in this approx-
imates ±30 ml per hour initially, falling to ±300 ml per day.
These represent large errors in small babies, who frequently
appear to be haemodynamically unstable on treatment, and often
require saline boluses to treat episodes of clinical hypovolaemia.
Conclusion
The unique design of the Nidus machine enables it to clear the
blood of chemicals and fluid in babies weighing between 800 g
and 8 kg, just using a single-lumen line, without blood priming,
and with microlitre UF control. It may become the treatment
modality of choice for many small babies with acute renal
failure, and may have roles to play in managing infants with
chronic renal failure. We anticipate that it will be commercially
available within a few months. So far it has only been used in
Newcastle, but we plan to undertake a prospective study of its
use across the UK to further determine its contribution to
managing infants requiring renal replacement therapies.
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